These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 25677227

  • 1. Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.
    Ticehurst MD, Marziano I.
    J Pharm Pharmacol; 2015 Jun; 67(6):782-802. PubMed ID: 25677227
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Selecting and controlling API crystal form for pharmaceutical development--strategies and processes.
    Yin SX, Grosso JA.
    Curr Opin Drug Discov Devel; 2008 Nov; 11(6):771-7. PubMed ID: 18946842
    [Abstract] [Full Text] [Related]

  • 4. The solid-state continuum: a perspective on the interrelationships between different solid-state forms in drug substance and drug product.
    Elder DP, Patterson JE, Holm R.
    J Pharm Pharmacol; 2015 Jun; 67(6):757-72. PubMed ID: 25124049
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.
    Cervera-Padrell AE, Skovby T, Kiil S, Gani R, Gernaey KV.
    Eur J Pharm Biopharm; 2012 Oct; 82(2):437-56. PubMed ID: 22820647
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Polymorphism and crystallization of active pharmaceutical ingredients (APIs).
    Lu J, Rohani S.
    Curr Med Chem; 2009 Oct; 16(7):884-905. PubMed ID: 19275600
    [Abstract] [Full Text] [Related]

  • 12. Crystal polymorphism in chemical process development.
    Lee AY, Erdemir D, Myerson AS.
    Annu Rev Chem Biomol Eng; 2011 Oct; 2():259-80. PubMed ID: 22432619
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of water in the physical stability of solid dosage formulations.
    Airaksinen S, Karjalainen M, Shevchenko A, Westermarck S, Leppänen E, Rantanen J, Yliruusi J.
    J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Drop-on-Demand System for Manufacturing of Melt-based Solid Oral Dosage: Effect of Critical Process Parameters on Product Quality.
    Içten E, Giridhar A, Nagy ZK, Reklaitis GV.
    AAPS PharmSciTech; 2016 Apr; 17(2):284-93. PubMed ID: 26082005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.